Concepedia

Omar Aziz

OA

Statistics

Publications

12

Citations

632

H-Index

12

Active since

2000

Affiliations

CHDI Foundation(Current)

Charles River Laboratories (United Kingdom)

King's College London

Newcastle University

Omar Aziz is an author at CHDI Foundation specializing in pharmacology, enzyme inhibition, and medicinal chemistry.

ORCID

Publications per year

2000–2022

12

Publications

12

Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease

Roland W. Bürli, Christopher A. Luckhurst, Omar Aziz et al. · Journal of Medicinal Chemistry · 2013 · 149 citations · Full text

, , +13

Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris

Alexander A. Navarini, Michael A. Simpson, Michael E. Weale et al. · Nature Communications · 2014 · 92 citations · Full text

, , +15

Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors

Christopher A. Luckhurst, Perla Breccia, Andrew J. Stott et al. · ACS Medicinal Chemistry Letters · 2015 · 55 citations · Full text

, , +10

2-Aminoethoxydiphenyl Borane Activates a Novel Calcium-Permeable Cation Channel

Franz-Josef Braun, Omar Aziz, James W. Putney · Molecular Pharmacology · 2003 · 52 citations

, , +17

Ca<sup>2+</sup> and cAMP‐activated Cl<sup>−</sup> conductances mediate Cl<sup>−</sup> secretion in a mouse renal inner medullary collecting duct cell line

Stefan H. Boese, M. Glanville, Omar Aziz et al. · The Journal of Physiology · 2000 · 50 citations · Full text

, , +17

1–5 of 12